Trafermin. CAB 2001, KCB 1, Fiblast.
D000818:Animals; D004285:Dogs; D015507:Drugs, Investigational / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D005346:Fibroblast Growth Factors / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D018696:Neuroprotective Agents / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D010446:Peptide Fragments / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D051381:Rats; D020521:Stroke / Q000188:drug therapy*
D015507:Drugs, Investigational; D018696:Neuroprotective Agents; D010446:Peptide Fragments; C114444:trafermin; D005346:Fibroblast Growth Factors